Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Anna Lantsova"'
Autor:
Anna Lantsova, Irina Golubeva, Larisa Borisova, Lyudmila Nikolaeva, Lydia Ektova, Maria Dmitrieva, Olga Orlova
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Objective The current scientific research direction is development of drugs with a targeted effect on malignant tumors. One of the promising groups is indolocarbazoles and their derivatives, which can initiate various tumor cell death pathwa
Externí odkaz:
https://doaj.org/article/d579c32b5eff4047b1aacab371ae33b5
Autor:
Ludmila Nikolaeva, Natalia Oborotova, Natalia Bunyatyan, Xi Zhang, Ekaterina Sanarova, Anna Lantsova, Olga Orlova, Alevtina Polozkova
Publikováno v:
Pharmaceuticals, Vol 9, Iss 4, p 68 (2016)
Despite the rapid development of medical technologies, chemotherapy treatment still occupies an important place in clinical oncology. In this regard, the current research in this area focuses on the synthesis of new highly effective antitumor substan
Externí odkaz:
https://doaj.org/article/b9d9e149d5bd42c6bb6f1aafd4e3a701
Autor:
Ludmila Nikolaeva, Maria Dmitrieva, Elena Ignatyeva, Anna Lantsova, O. L. Orlova, Alexander Kolpaksidi, Ivan I. Krasnyuk
Publikováno v:
International Journal of Applied Pharmaceutics. :232-235
Objective: Development of a technology for the production of a stable injectable dosage form (IDF) of indolocarbazole derivative LHS-1269. Methods: LHS-1269 is an active pharmaceutical ingredient that was synthesized in the N. N. Blokhin National Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a140870676a8613030ed27ab281570ac
https://doi.org/10.22159/ijap.2021v13i6.42685
https://doi.org/10.22159/ijap.2021v13i6.42685
Autor:
Nataliya Oborotova, Anna Lantsova, L. L. Nikolaeva, O. L. Orlova, Ilya Gulyakin, Maria Dmitrieva, Natalia Zhuravleva
Publikováno v:
International Journal of Applied Pharmaceutics. :102-105
Objective: Development of a lyophilized injectable dosage form LCS-1208, an original antitumor drug based on an indolocarbazole derivative. Methods: The prepared solution of the injectable dosage form LCS-1208 is transferred to sterilizing filtration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8eeaeb92104ec93a4d1d5711c5983eb
https://doi.org/10.22159/ijap.2021v13i4.41371
https://doi.org/10.22159/ijap.2021v13i4.41371
Autor:
Elena Ignatyeva, Ludmila Nikolaeva, O. L. Orlova, Zoya Shprakh, Anna Lantsova, Maria Dmitrieva, Ivan I. Krasnyuk
Publikováno v:
International Journal of Applied Pharmaceutics. :65-68
Objective: Was to create the composition of the liposomal pharmaceutical form for injections of somatostatin analogue cyphetrylin using soybean phosphatidylcholine (SPC). Methods: The cyphetrylin, active pharmaceutical ingredient (API), developed in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0b00b78247f32cb0331fcbcec9ae8d3
https://doi.org/10.22159/ijap.2020v12i6.39253
https://doi.org/10.22159/ijap.2020v12i6.39253
Autor:
Ekaterina Sanarova, L. L. Nikolaeva, O. L. Orlova, N. A. Oborotova, Maria Dmitrieva, Anna Lantsova, N. D. Bunyatyan, Galina Glembotskaya
Publikováno v:
International Journal of Applied Pharmaceutics. :241-244
Objective: This study was undertaken with the aim of the validate the simple isocratic metods high-performance liquid chromatographic (HPLC) for the estimation of PEG-2000-DSPE and sucrose in liposomal medicinal formulations of the phthalocyanine pho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdd95d76a5cf453d9cd4b992afc0d251
https://doi.org/10.22159/ijap.2020v12i6.38374
https://doi.org/10.22159/ijap.2020v12i6.38374
Autor:
N. P. Ermakova, N. D. Bunyatyan, O. L. Orlova, O. I. Konyaeva, Nataliya Kulbachevskaya, Anna Lantsova, Pavel Varaksa, L. L. Nikolaeva, V. A. Chaley, Yuliya Rodionova
Publikováno v:
Drug research. 71(9)
Objective Study of embryotoxicity, teratogenicity and reproductive toxicity of the new drug Lipophtalocyan in rats. Material and Methods Studies were conducted on 210 non-inbred female rats and 105 non-inbred male rats. The drug was administered dail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b71b79bbc5e94de6f71f90f43f228648
https://pubmed.ncbi.nlm.nih.gov/34327700
https://pubmed.ncbi.nlm.nih.gov/34327700
Autor:
L. L. Nikolaeva, Larisa Borisova, Irina Golubeva, Lydia Ektova, Maria Dmitrieva, Anna Lantsova, O. L. Orlova
Publikováno v:
BMC Complementary Medicine and Therapies
BMC Complementary Medicine and Therapies, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Complementary Medicine and Therapies, Vol 21, Iss 1, Pp 1-8 (2021)
Objective The current scientific research direction is development of drugs with a targeted effect on malignant tumors. One of the promising groups is indolocarbazoles and their derivatives, which can initiate various tumor cell death pathways. Russi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66360fedd8cc8e0f22f2c77480fe3689
https://pubmed.ncbi.nlm.nih.gov/33838683
https://pubmed.ncbi.nlm.nih.gov/33838683
Autor:
N. A. Oborotova, L. L. Nikolaeva, O. I. Konyaeva, Z. S. Shprakh, A. P. Polozkova, Anna Lantsova, M. V. Dmitrieva, O. L. Orlova, N. Yu. Kul’bachevskaya
Publikováno v:
Farmaciya (Pharmacy). 68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f3e0369f7fe46fbfb447370ee085e69
https://doi.org/10.29296/25419218-2019-04-03
https://doi.org/10.29296/25419218-2019-04-03
Autor:
E. V. Sanarova, N. A. Oborotova, A. P. Polozkova, O. L. Orlova, L. L. Nikolaeva, Anna Lantsova
Publikováno v:
Nanotechnologies in Russia. 11:371-376
The improvement of the composition and technology for the preparation of the liposomal dosage form of ormustine is under consideration. Liposomes are prepared from egg lecithin, cholesterol, and PEG-2000-DSPE by the film hydration method, with 0.1% c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::093abbcf09512617acd2ce54858cd7e6
https://doi.org/10.1134/s1995078016030125
https://doi.org/10.1134/s1995078016030125